Effects of Chia Seed Consumption in Comparison With Marine Omega-3 Supplementation on the Concentration of Blood Lipid and Inflammatory Factors in Hypertriglyceridemic Patients
Control
+ Omega-3 supplementation
+ Chia seed
Hyperlipidemias+3
+ Metabolic Diseases
+ Nutritional and Metabolic Diseases
Prevention Study
Summary
Study start date: September 18, 2023
Actual date on which the first participant was enrolled.This clinical trial investigates the effects of consuming chia seeds compared to marine omega-3 supplements on people with mild to moderate high triglycerides, a condition known as hypertriglyceridemia. Individuals with specific health conditions like severe kidney disease, AIDS, cancer under treatment, liver cirrhosis, and those using certain medications or supplements are not eligible to participate. The study aims to explore new dietary approaches to manage triglyceride levels and inflammation, potentially offering alternative options to improve heart health and reduce the risk of related complications. Participants in this study are divided into three groups for eight weeks. One group receives placebo capsules containing sunflower oil, another takes omega-3 capsules, and the third consumes chia seeds. All participants follow a low-calorie diet during the trial. Researchers assess changes by measuring body weight, blood pressure, and blood levels of lipids, lipoproteins, and inflammation markers at the start and end of the study. This helps determine the effectiveness of chia seeds and omega-3 supplements in managing blood triglycerides and inflammation.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.66 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
Active ComparatorGroup III
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute
Tehran, IranOpen Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute in Google Maps